Evidence map›Paper›PMID 42459815›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2026

Landscape of current practices and future perspectives in living donor kidney donation in Europe: proceedings of a pan-European symposium by the European kidney transplant association section of the European Society for Organ Transplantation.

Andreas Kousios, Marije Baas, Anna Manonelles, Fernanda Ortiz, Elvana Rista, Rachel Thomas, Carmen Lefaucheur, Emin Baris Akin, Lorna Marson

Abstract readConference Proceedings
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andreas KousiosSchool of Medicine, European University Cyprus, Nicosia, Cyprus.
Marije BaasDepartment of Nephrology, Radboud University Medical Center, Radboud Universiteit, Nijmegen, Netherlands.
Anna ManonellesRenal Transplant Unit, Nephrology Department, Bellvitge University Hospital, Barcelona, Spain.
Fernanda OrtizAbdominal Unit, Nephrology, Helsinki University Hospital, Helsinki, Finland.
Elvana RistaDepartment of Nephrology, Dialysis, and Kidney Transplantation, Hygeia International Hospital, Tirana, Albania.
Rachel ThomasEdinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
Carmen LefaucheurSaint Louis Hospital, Assistance Publique- Hopiteux de Paris and Université Paris Cité, Paris, France.
Emin Baris AkinDepartment of General Surgery, Demiroglu Bilim University and Group Florence Nightingale Hospital, Istanbul, Türkiye.
Lorna MarsonEdinburgh Transplant Centre, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Living donor kidney transplantation (LDKT) offers superior outcomes for most patients with end-stage kidney disease (ESKD), yet its uptake across Europe remains highly variable. This proceedings article summarizes key themes from a pan-European symposium held in November 2025 in Prague, organized by the European Kidney Transplant Association (EKITA) in collaboration with the DESCaRTES Working Group. Discussions highlighted substantial heterogeneity in LDKT activity across Europe, driven by differences in healthcare capacity, legal frameworks, donor evaluation practices, and access to kidney exchange programmes. Marked inequities persist between regions, particularly in the Balkans and Western Balkans, for women those who are socioeconomically disadvantaged, ethnic minority populations, paediatric and elderly patients and individuals with obesity. The symposium identified wide variation in donor selection criteria, risk assessment, informed consent practices, and long-term donor follow-up, despite existing international guidelines. Emerging strategies to address these challenges include harmonisation of donor evaluation and consent, expansion of paired and cross-border kidney exchange programmes, increased use of unspecified kidney donation, and adoption of innovative surgical and immunological approaches to safely broaden donor eligibility. Advances in outcome measurement, including validated surrogate endpoints, machine learning methods, and integrated, harmonised transplant registries, were discussed as critical tools to improve quality, transparency, and research efficiency. Collectively, the proceedings underscore the need for coordinated clinical, policy, and data-driven solutions to reduce inequities and unlock the full potential of LDKT across Europe, with implications for international transplant practice.

Indexed as

Kidney Failure, ChronicKidney TransplantationLiving DonorsTissue and Organ ProcurementDonor SelectionEuropeFemaleHumansInformed ConsentRisk Assessmentcross-border organ exchangedonor evaluation and safetyequity in transplantationliving donor kidney transplantationtransplant registry harmonisation

Identifiers

PMID42459815
PMCPMC13368691

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.